Plain-English translation of NCT05950087 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research is studying whether certain markers found in blood can help predict how well chemotherapy and radiation therapy work for people with locally advanced cervical cancer. Researchers will collect blood samples before, during, and after your treatment to measure these markers. The goal is to develop a simple blood test that could help doctors better predict which patients will respond well to treatment and which ones might need a different approach.
Most people with advanced cervical cancer are not cured with current treatments alone, and doctors don't have a reliable way to know early on whether the treatment is working. This study aims to find a blood-based marker that could predict treatment success much sooner, before imaging scans show results, potentially allowing doctors to adjust treatment plans faster.
You likely qualify if…
You likely don't qualify if…
You will receive your standard chemotherapy and radiation therapy for cervical cancer as planned. In addition, you will have blood drawn before your treatment starts, possibly during treatment, and after treatment is complete to measure the special markers researchers are studying. You will also need imaging scans (CT or PET scans) and regular follow-up visits to track how you're responding. The study involves about 30 patients total and will help doctors understand whether these blood markers can predict treatment success.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China